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Letters to the Editorbe a blowout at the previous aortot-
omy site, because there was no evi-
dence of aortic wall infection
intraoperatively, and histologic exam-
ination and cultures taken from the
pseudoaneurysm remained sterile.
The patient was discharged 4 weeks
later. Heart and prosthetic valve func-
tion were normal, and computed
tomography scan showed no abnor-
mality (Figure 1). We think operation
for ascending aortic pseudoaneurysms
can be safely performed on femorofe-
moral bypass without hypothermic
cardiac arrest.
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CORONARYARTERY BYPASS
GRAFTING: DOES
RHABDOMYOLYSIS PLAY
A ROLE?
To the Editor:
In the August 2010 edition of this
Journal, Periopertive Management
section, the following article was pub-
lished: ‘‘Acute kidney injury after cor-The Journalonary artery bypass grafting: Does
rhabdomyolysis play a role?’’ by Ben-
edetto et al.
The study has hypothesized that
rhabdomyolysis may play a role in
the development of acute kidney in-
jury after coronary artery bypass
grafting. However some important
considerations have been ignored in
the study. (1) The use of depolarizing
muscle relaxant suxamethonium is not
mentioned. Suxamethonium has been
previously shown in literature as a po-
tential cause of muscle injury and
rhabdomyolysis. This is even more
important when given to obese pa-
tients. (2) The use of antifibrinolytic
medications aminocaproic acid (Ami-
car) and tranexamic acid (Cyclokap-
ron) is also not mentioned. Several
case reports have associated rhabdo-
myolysis with their concurrent use in
cardiac surgery. (3) The use of the an-
tiarrhythmic drug amiodarone has not
been addressed. Amiodarone has also
been associated with acute renal in-
jury, especially when used along
with statins. (4) All statins carry
a risk of rhabdomyolysis. However,
the Food and Drug Administration au-
thority has said that the risk of rhabho-
myolysis developing is more
pronounced when simvastatin is com-
bined with amiodarone than it is with
other statin medications. The study
has not provided the different statin
medications the patients were receiv-
ing. (5) The study failed to mention
whether the statin therapy was opti-
mized before the operation. (6) The
anesthetic technique used is totally ig-
nored. Use of several inhalational
agents could potentially increase the
likelihood of renal injury developing,
especially in combination with afore-
mentioned drugs. Was total intrave-
nous anesthesia technique used in
any of the patients in the study? (7)
No information was given about con-
current use of mannitol (especially
during cardiopulmonary bypass).
It is very important to consider all
possible causes of rhabdomyolysis
that can occur during coronary arteryof Thoracic and Cardiovascular Surgebypass grafting. I wish to know from
Benedetto and associates the informa-
tion regarding these questions.
Srikiran Ramarapu
Oklahoma University
Department of Anesthesiology
Oklahoma City, Okla
doi:10.1016/j.jtcvs.2010.09.060Reply to the Editor:
We appreciate the interest in our
work1 and are pleased to address the
aroused considerations.
First, we use cisatracurium, and not
suxamethonium, as a muscle relaxant.
We do not use aminocaproic acid or
tranexamic acid, which is why these
drugs are not mentioned in our article.1
Amiodarone, which is known to play
a role in rhabdomyolysis develop-
ment,2 was entered in themultivariable
correction, but no statistically signifi-
cant correlation was found (P ¼ .75).
Unfortunately, we could not retrieve
information on the different types of
statins that patients were taking be-
cause there were several and it was
a retrospective study; however, we do
know that atorvastatin, simvastatin, ro-
suvastatin, fluvastatin, and pravastatin
were used. Nevertheless, consistent
with the latest guidelines,3 statin ther-
apy was optimized before surgery to
achieve a low-density lipoprotein cho-
lesterol level less than 100 mg/dL, and
this was achieved in 85% of patients.
Anesthetic induction was obtained by
means of sevoflurane, and propofol
was used as maintenance. We believe
these agents do not increase the hazard
of renal impairment. Finally, mannitol
is routinely administered during car-
diopulmonary bypass at a small dose
of 200 to 250 mg.
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